{{Rsnum
|rsid=2279344
|Gene=CYP2B6
|Chromosome=19
|position=41009578
|Orientation=plus
|GMAF=0.2792
|Gene_s=CYP2B6
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 35.4 | 50.4 | 14.2
| HCB | 50.4 | 38.0 | 11.7
| JPT | 39.8 | 53.1 | 7.1
| YRI | 81.6 | 17.0 | 1.4
| ASW | 66.7 | 28.1 | 5.3
| CHB | 50.4 | 38.0 | 11.7
| CHD | 41.3 | 47.7 | 11.0
| GIH | 68.3 | 28.7 | 3.0
| LWK | 84.5 | 14.5 | 0.9
| MEX | 62.1 | 36.2 | 1.7
| MKK | 85.3 | 14.7 | 0.0
| TSI | 45.1 | 44.1 | 10.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=23249875
|Title=Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels:  a CYP2B6 gene resequencing study
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}